NCT00012129View on ClinicalTrials.gov

Chemotherapy in Treating Patients With Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1998

Primary Completion Date

May 31, 2001

Conditions
Breast Cancer
Interventions
DRUG

liposomal annamycin

Trial Locations (1)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00012129 - Chemotherapy in Treating Patients With Breast Cancer | Biotech Hunter | Biotech Hunter